IC Oversight & Authorities — 2026-06-12
Gabbard Releases Intelligence Identifying 120 US-Funded Biolabs in 30 Countries Conducting Gain-of-Function Research
BLUFFormal congressional hearings on foreign biolab funding remain unlikely before October given that the declassified material repackages long-public CTR program records rather than exposing genuinely concealed activity.
DNI Gabbard's office released partially redacted declassified documents on June 12 identifying U.S. government funding for more than 120 biolabs in over 30 countries, with Newsweek reporting Ukraine accounts for more than 40 of those sites 123. The ODNI press release states the documents were declassified in April and that evidence had been "knowingly withheld from the American people" by prior administrations; Gabbard simultaneously issued new IC guidance directing increased collection on the labs globally 1. The declassified slides identify pathogens stored at Ukrainian facilities as including anthrax, avian flu, Ebola, plague, and tuberculosis, with ODNI's own reporting previously warning at least one facility remained vulnerable to Russian attack, seizure, or damage 14. Radio Free Europe/Radio Liberty noted it was unclear whether the release contained anything "new or revelatory," given longstanding U.S. funding through the Cooperative Threat Reduction program 4.
AnalysisFormal committee hearings on U.S. foreign biolab funding are
unlikely by September 30, 2026: congressional Republicans extract more political value from Gabbard's cover-up framing as a messaging instrument than from proceedings that would require scrutinizing a program their own administrations continued and expanded. The CTR program's decades-long public record undercuts the novelty claim and reduces legislative urgency. Low confidence reflects a sole primary source, ODNI reporting on its own disclosure, with no independent corroboration of the suppression claim and no observable indicators of hearing scheduling. Republican committee chairs with aligned political incentives may yet schedule hearings to amplify the narrative ahead of the 2026 midterms, using the oversight mechanism as a messaging vehicle rather than accountability. Absent hearings, successor foreign research arrangements remain at executive discretion through at least the next Congress.
5 sources
- DNI Gabbard Reveals Evidence of U.S. Taxpayer-Funded Global Biolab Program - Office of the Director of National Intelligence
- Gabbard Reveals Declassified Map, Records of Ukraine Bio Labs - Newsweek
- Gabbard says US biolab finding spans more than 30 countries amid ODNI fight - Washington Examiner
- US Releases Taxpayer-Funded Information On Biolabs In Over 30 Countries, Including Ukraine - Radio Free Europe/Radio Liberty
- Gabbard releases intelligence showing federal government has funded 120 biolabs in 30 countries - Just The News
View in full brief →